Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Oppenheimer Holdings Inc is a capital markets business based in the US. Oppenheimer shares (OPY) are listed on the NYSE and all prices are listed in US Dollars. Oppenheimer employs 2,854 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$49.97|
|52-week range||$20.20 - $55.75|
|50-day moving average||$47.71|
|200-day moving average||$43.42|
|Wall St. target price||$37.00|
|Dividend yield||$0.48 (1.1%)|
|Earnings per share (TTM)||$11.67|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-07-22)||N/A|
|1 month (2021-07-02)||-1.32%|
|3 months (2021-04-30)||-2.35%|
|6 months (2021-01-29)||N/A|
|1 year (2020-07-29)||N/A|
|2 years (2019-07-29)||N/A|
|3 years (2018-07-29)||N/A|
|5 years (2016-07-29)||N/A|
Valuing Oppenheimer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Oppenheimer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Oppenheimer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Oppenheimer shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Oppenheimer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 12. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Oppenheimer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$1.3 billion|
|Operating margin TTM||22.66%|
|Gross profit TTM||$1.1 billion|
|Return on assets TTM||6.35%|
|Return on equity TTM||23.55%|
|Market capitalisation||$572.8 million|
TTM: trailing 12 months
There are currently 308,007 Oppenheimer shares held short by investors – that's known as Oppenheimer's "short interest". This figure is 120.5% up from 139,660 last month.
There are a few different ways that this level of interest in shorting Oppenheimer shares can be evaluated.
Oppenheimer's "short interest ratio" (SIR) is the quantity of Oppenheimer shares currently shorted divided by the average quantity of Oppenheimer shares traded daily (recently around 125206.09756098). Oppenheimer's SIR currently stands at 2.46. In other words for every 100,000 Oppenheimer shares traded daily on the market, roughly 2460 shares are currently held short.
However Oppenheimer's short interest can also be evaluated against the total number of Oppenheimer shares, or, against the total number of tradable Oppenheimer shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Oppenheimer's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Oppenheimer shares in existence, roughly 20 shares are currently held short) or 0.0366% of the tradable shares (for every 100,000 tradable Oppenheimer shares, roughly 37 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Oppenheimer.
Find out more about how you can short Oppenheimer stock.
Dividend payout ratio: 11.32% of net profits
Recently Oppenheimer has paid out, on average, around 11.32% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.06% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Oppenheimer shareholders could enjoy a 1.06% return on their shares, in the form of dividend payments. In Oppenheimer's case, that would currently equate to about $0.48 per share.
While Oppenheimer's payout ratio might seem low, this can signify that Oppenheimer is investing more in its future growth.
Oppenheimer's most recent dividend payout was on 27 May 2021. The latest dividend was paid out to all shareholders who bought their shares by 12 May 2021 (the "ex-dividend date").
Over the last 12 months, Oppenheimer's shares have ranged in value from as little as $20.2031 up to $55.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Oppenheimer's is 1.1507. This would suggest that Oppenheimer's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Oppenheimer Holdings Inc. , through its subsidiaries, operates as a middle-market investment bank and full-service broker-dealer in the Americas, Europe, the Middle East, and Asia. The company offers brokerage services covering exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, exchange-traded funds, and unit investment trusts; financial and wealth planning services; and margin lending services. It also provides asset management services, including separately managed accounts, mutual fund managed accounts, discretionary portfolio management programs, non-discretionary investment advisory and consultation services, alternative investments, portfolio enhancement programs, and institutional taxable fixed income portfolio management strategies and solutions, as well as taxable and non-taxable fixed income portfolios and strategies. In addition, the company offers investment banking services, such as strategic advisory services and capital markets products; merger and acquisition, equities capital market, and debt capital market products and services; and institutional equity sales and trading, equity research, equity derivatives and index options, convertible bonds, and trading services. Further, it provides institutional fixed income sales and trading, fixed income research, public finance, and municipal trading services; repurchase agreements and securities lending services; and proprietary trading and investment activities. Additionally, the company offers underwritings, market-making, trust, and discount services.
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
Everything we know about the RenovoRx IPO, plus information on how to buy in.
Everything we know about the Draganfly IPO, plus information on how to buy in.
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
Everything we know about the Marpai IPO, plus information on how to buy in.
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.